PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Uppsala Monitoring Centre, Uppsala, Sweden. elena.rocca@nmbu.no.\', \'Centre for Applied Philosophy of Science, Norwegian University of Life Sciences, Ås, Norway. elena.rocca@nmbu.no.\', \'Uppsala Monitoring Centre, Uppsala, Sweden.\', \'Division of Health Sciences, New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand.\', \'Department of General Practice, University of Otago, Christchurch, New Zealand.\', \'Uppsala Monitoring Centre, Uppsala, Sweden. birgitta.grundmark@who-umc.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40264-021-01091-x
?:hasPublicationType
?:journal
  • Drug safety
is ?:pmid of
?:pmid
?:pmid
  • 34374967
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.447
?:rankingScore_hIndex
  • 112
?:title
  • Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34374967>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34374967>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all